These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6707876)

  • 1. High-performance liquid chromatographic analysis of the semisynthetic epipodophyllotoxins teniposide and etoposide using electrochemical detection.
    Sinkule JA; Evans WE
    J Pharm Sci; 1984 Feb; 73(2):164-8. PubMed ID: 6707876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated liquid chromatographic analysis of the anti-tumorigenic drugs etoposide (VP 16-213) and teniposide (VM 26).
    Werkhoven-Goewie CE; Brinkman UA; Frei RW; de Ruiter C; de Vries J
    J Chromatogr; 1983 Sep; 276(2):349-57. PubMed ID: 6630384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated reversed-phase chromatographic analysis of etoposide and teniposide in plasma by using on-line surfactant-mediated sample clean-up and column-switching.
    van Opstal MA; van der Horst FA; Holthuis JJ; van Bennekom WP; Bult A
    J Chromatogr; 1989 Oct; 495():139-51. PubMed ID: 2613799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay for etoposide and teniposide.
    Ho DH; Kanellopoulos KS; Brown NS; Issell BF; Bodey GP
    J Immunol Methods; 1985 Dec; 85(1):5-15. PubMed ID: 4078312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the anticancer drugs VP 16-213 and VM 26 and their metabolites by high-performance liquid chromatography.
    Strife RJ; Jardine I; Colvin M
    J Chromatogr; 1980 May; 182(2):211-20. PubMed ID: 7380913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatographic assay for etoposide in human plasma.
    Hersh MR; Ludden TM
    J Pharm Sci; 1986 Aug; 75(8):815-7. PubMed ID: 3772756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the anticancer drugs etoposide (VP 16-213) and teniposide (VM 26) by high-performance liquid chromatography with fluorescence detection.
    Strife RJ; Jardine I; Colvin M
    J Chromatogr; 1981 Jun; 224(1):168-74. PubMed ID: 7263816
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantification of teniposide in human serum by high-performance liquid chromatography with electrochemical detection.
    Canal P; Michel C; Bugat R; Soula G; Carton M
    J Chromatogr; 1986 Mar; 375(2):451-6. PubMed ID: 3700571
    [No Abstract]   [Full Text] [Related]  

  • 9. Etoposide and teniposide. Bioanalysis, metabolism and clinical pharmacokinetics.
    Holthuis JJ
    Pharm Weekbl Sci; 1988 Jun; 10(3):101-16. PubMed ID: 3047665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical pharmacology of etoposide and teniposide.
    Clark PI; Slevin ML
    Clin Pharmacokinet; 1987 Apr; 12(4):223-52. PubMed ID: 3297462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance liquid chromatographic determination of etoposide in plasma using electrochemical detection.
    Littlewood TJ; Hutchings AL; Bentley DP; Spragg BP
    J Chromatogr; 1984 Dec; 336(2):434-7. PubMed ID: 6530477
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of Teniposide (VM26) and etoposide (VP16-213) in children with cancer.
    Evans WE; Sinkule JA; Crom WR; Dow L; Look AT; Rivera G
    Cancer Chemother Pharmacol; 1982; 7(2-3):147-50. PubMed ID: 7083455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the concentration of VP 16 and VM 26 in human brain neoplasms].
    Zucchetti M; Rossi C; Gaetani P; Silvani V; Knerich R; Butti G; Donelli MG; D'Incalci M
    G Ital Chemioter; 1985; 32(1):83-6. PubMed ID: 3830796
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of teniposide in rat plasma by ultra performance liquid chromatography electrospray ionization tandem mass spectrometry after intravenous administration.
    Wang J; Zhang Y; Guan T; Lin X; Tang X; Xu H
    Biomed Chromatogr; 2009 Sep; 23(9):999-1006. PubMed ID: 19382244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-performance liquid chromatography with fluorometric detection for monitoring of etoposide and its cis-isomer in plasma and leukaemic cells.
    Liliemark E; Pettersson B; Peterson C; Liliemark J
    J Chromatogr B Biomed Appl; 1995 Jul; 669(2):311-7. PubMed ID: 7581907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of teniposide (VM 26) after IV administration in serum and malignant ascites of patients with ovarian carcinoma.
    Canal P; Bugat R; Michel C; Roche H; Soula G; Combes PF
    Cancer Chemother Pharmacol; 1985; 15(2):149-52. PubMed ID: 4017164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxidative free radical formation and O-demethylation of etoposide(VP-16) and teniposide(VM-26).
    Haim N; Roman J; Nemec J; Sinha BK
    Biochem Biophys Res Commun; 1986 Feb; 135(1):215-20. PubMed ID: 3006680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability-indicating liquid chromatographic determination of etoposide and benzyl alcohol in injectable formulations.
    Floor BJ; Klein AE; Muhammad N; Ross D
    J Pharm Sci; 1985 Feb; 74(2):197-200. PubMed ID: 3989692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-performance liquid chromatography of etoposide in plasma and urine.
    Harvey VJ; Joel SP; Johnston A; Slevin ML
    J Chromatogr; 1985 May; 339(2):419-23. PubMed ID: 4008582
    [No Abstract]   [Full Text] [Related]  

  • 20. Improved assay for etoposide in plasma by radial-compression liquid chromatography with electrochemical detection.
    el-Yazigi A; Martin CR
    Clin Chem; 1987 Jun; 33(6):803-5. PubMed ID: 3594819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.